0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pravastatin Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-34M6796
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pravastatin Market Insights Forecast to 2028
BUY CHAPTERS

Global Pravastatin Market Research Report 2025

Code: QYRE-Auto-34M6796
Report
August 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

The global market for Pravastatin was valued at US$ 614 million in the year 2024 and is projected to reach a revised size of US$ 931 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Pravastatin Market

Pravastatin Market

Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.
North American market for Pravastatin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pravastatin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pravastatin include Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pravastatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pravastatin.
The Pravastatin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pravastatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pravastatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pravastatin Market Report

Report Metric Details
Report Name Pravastatin Market
Accounted market size in year US$ 614 million
Forecasted market size in 2031 US$ 931 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 10mg Tablet
  • 20mg Tablet
  • 40mg Tablet
  • 80mg Tablet
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, Aurobindo Pharma, Accord Healthcare, Upsher-Smith Laboratories, Hisun, Jiangxi Boyaseehot Pharmaceutical, Shanghai Shyndec Pharmaceutical, Daiichi Sankyo, North China Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pravastatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pravastatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pravastatin Market growing?

Ans: The Pravastatin Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Pravastatin Market size in 2031?

Ans: The Pravastatin Market size in 2031 will be US$ 931 million.

Who are the main players in the Pravastatin Market report?

Ans: The main players in the Pravastatin Market are Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, Aurobindo Pharma, Accord Healthcare, Upsher-Smith Laboratories, Hisun, Jiangxi Boyaseehot Pharmaceutical, Shanghai Shyndec Pharmaceutical, Daiichi Sankyo, North China Pharmaceutical Group

What are the Application segmentation covered in the Pravastatin Market report?

Ans: The Applications covered in the Pravastatin Market report are Adults, Children

What are the Type segmentation covered in the Pravastatin Market report?

Ans: The Types covered in the Pravastatin Market report are 10mg Tablet, 20mg Tablet, 40mg Tablet, 80mg Tablet

Recommended Reports

Cardiovascular Drugs

Statins & Lipid-Lowering

Pharma Ingredients

1 Pravastatin Market Overview
1.1 Product Definition
1.2 Pravastatin by Type
1.2.1 Global Pravastatin Market Value Comparison by Type (2024 VS 2031)
1.2.2 10mg Tablet
1.2.3 20mg Tablet
1.2.4 40mg Tablet
1.2.5 80mg Tablet
1.3 Pravastatin by Application
1.3.1 Global Pravastatin Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Pravastatin Market Size Estimates and Forecasts
1.4.1 Global Pravastatin Revenue 2020-2031
1.4.2 Global Pravastatin Sales 2020-2031
1.4.3 Global Pravastatin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pravastatin Market Competition by Manufacturers
2.1 Global Pravastatin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pravastatin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pravastatin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pravastatin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pravastatin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pravastatin, Product Type & Application
2.7 Global Key Manufacturers of Pravastatin, Date of Enter into This Industry
2.8 Global Pravastatin Market Competitive Situation and Trends
2.8.1 Global Pravastatin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pravastatin Players Market Share by Revenue
2.8.3 Global Pravastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pravastatin Market Scenario by Region
3.1 Global Pravastatin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pravastatin Sales by Region: 2020-2031
3.2.1 Global Pravastatin Sales by Region: 2020-2025
3.2.2 Global Pravastatin Sales by Region: 2026-2031
3.3 Global Pravastatin Revenue by Region: 2020-2031
3.3.1 Global Pravastatin Revenue by Region: 2020-2025
3.3.2 Global Pravastatin Revenue by Region: 2026-2031
3.4 North America Pravastatin Market Facts & Figures by Country
3.4.1 North America Pravastatin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pravastatin Sales by Country (2020-2031)
3.4.3 North America Pravastatin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pravastatin Market Facts & Figures by Country
3.5.1 Europe Pravastatin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pravastatin Sales by Country (2020-2031)
3.5.3 Europe Pravastatin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pravastatin Market Facts & Figures by Region
3.6.1 Asia Pacific Pravastatin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pravastatin Sales by Region (2020-2031)
3.6.3 Asia Pacific Pravastatin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pravastatin Market Facts & Figures by Country
3.7.1 Latin America Pravastatin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pravastatin Sales by Country (2020-2031)
3.7.3 Latin America Pravastatin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pravastatin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pravastatin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pravastatin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pravastatin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pravastatin Sales by Type (2020-2031)
4.1.1 Global Pravastatin Sales by Type (2020-2025)
4.1.2 Global Pravastatin Sales by Type (2026-2031)
4.1.3 Global Pravastatin Sales Market Share by Type (2020-2031)
4.2 Global Pravastatin Revenue by Type (2020-2031)
4.2.1 Global Pravastatin Revenue by Type (2020-2025)
4.2.2 Global Pravastatin Revenue by Type (2026-2031)
4.2.3 Global Pravastatin Revenue Market Share by Type (2020-2031)
4.3 Global Pravastatin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pravastatin Sales by Application (2020-2031)
5.1.1 Global Pravastatin Sales by Application (2020-2025)
5.1.2 Global Pravastatin Sales by Application (2026-2031)
5.1.3 Global Pravastatin Sales Market Share by Application (2020-2031)
5.2 Global Pravastatin Revenue by Application (2020-2031)
5.2.1 Global Pravastatin Revenue by Application (2020-2025)
5.2.2 Global Pravastatin Revenue by Application (2026-2031)
5.2.3 Global Pravastatin Revenue Market Share by Application (2020-2031)
5.3 Global Pravastatin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Pravastatin Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 TEVA
6.2.1 TEVA Company Information
6.2.2 TEVA Description and Business Overview
6.2.3 TEVA Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 TEVA Pravastatin Product Portfolio
6.2.5 TEVA Recent Developments/Updates
6.3 SANDOZ
6.3.1 SANDOZ Company Information
6.3.2 SANDOZ Description and Business Overview
6.3.3 SANDOZ Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SANDOZ Pravastatin Product Portfolio
6.3.5 SANDOZ Recent Developments/Updates
6.4 APOTEX
6.4.1 APOTEX Company Information
6.4.2 APOTEX Description and Business Overview
6.4.3 APOTEX Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 APOTEX Pravastatin Product Portfolio
6.4.5 APOTEX Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Reddy's Laboratories Pravastatin Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Company Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zydus Pharmaceuticals Pravastatin Product Portfolio
6.6.5 Zydus Pharmaceuticals Recent Developments/Updates
6.7 Cipla Inc.
6.7.1 Cipla Inc. Company Information
6.7.2 Cipla Inc. Description and Business Overview
6.7.3 Cipla Inc. Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Inc. Pravastatin Product Portfolio
6.7.5 Cipla Inc. Recent Developments/Updates
6.8 Lupin Pharmaceuticals
6.8.1 Lupin Pharmaceuticals Company Information
6.8.2 Lupin Pharmaceuticals Description and Business Overview
6.8.3 Lupin Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lupin Pharmaceuticals Pravastatin Product Portfolio
6.8.5 Lupin Pharmaceuticals Recent Developments/Updates
6.9 Glenmark
6.9.1 Glenmark Company Information
6.9.2 Glenmark Description and Business Overview
6.9.3 Glenmark Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Glenmark Pravastatin Product Portfolio
6.9.5 Glenmark Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Company Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Pravastatin Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Company Information
6.11.2 Aurobindo Pharma Description and Business Overview
6.11.3 Aurobindo Pharma Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aurobindo Pharma Pravastatin Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Accord Healthcare
6.12.1 Accord Healthcare Company Information
6.12.2 Accord Healthcare Description and Business Overview
6.12.3 Accord Healthcare Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Accord Healthcare Pravastatin Product Portfolio
6.12.5 Accord Healthcare Recent Developments/Updates
6.13 Upsher-Smith Laboratories
6.13.1 Upsher-Smith Laboratories Company Information
6.13.2 Upsher-Smith Laboratories Description and Business Overview
6.13.3 Upsher-Smith Laboratories Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Upsher-Smith Laboratories Pravastatin Product Portfolio
6.13.5 Upsher-Smith Laboratories Recent Developments/Updates
6.14 Hisun
6.14.1 Hisun Company Information
6.14.2 Hisun Description and Business Overview
6.14.3 Hisun Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hisun Pravastatin Product Portfolio
6.14.5 Hisun Recent Developments/Updates
6.15 Jiangxi Boyaseehot Pharmaceutical
6.15.1 Jiangxi Boyaseehot Pharmaceutical Company Information
6.15.2 Jiangxi Boyaseehot Pharmaceutical Description and Business Overview
6.15.3 Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Portfolio
6.15.5 Jiangxi Boyaseehot Pharmaceutical Recent Developments/Updates
6.16 Shanghai Shyndec Pharmaceutical
6.16.1 Shanghai Shyndec Pharmaceutical Company Information
6.16.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.16.3 Shanghai Shyndec Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Shanghai Shyndec Pharmaceutical Pravastatin Product Portfolio
6.16.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.17 Daiichi Sankyo
6.17.1 Daiichi Sankyo Company Information
6.17.2 Daiichi Sankyo Description and Business Overview
6.17.3 Daiichi Sankyo Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Daiichi Sankyo Pravastatin Product Portfolio
6.17.5 Daiichi Sankyo Recent Developments/Updates
6.18 North China Pharmaceutical Group
6.18.1 North China Pharmaceutical Group Company Information
6.18.2 North China Pharmaceutical Group Description and Business Overview
6.18.3 North China Pharmaceutical Group Pravastatin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 North China Pharmaceutical Group Pravastatin Product Portfolio
6.18.5 North China Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pravastatin Industry Chain Analysis
7.2 Pravastatin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pravastatin Production Mode & Process Analysis
7.4 Pravastatin Sales and Marketing
7.4.1 Pravastatin Sales Channels
7.4.2 Pravastatin Distributors
7.5 Pravastatin Customer Analysis
8 Pravastatin Market Dynamics
8.1 Pravastatin Industry Trends
8.2 Pravastatin Market Drivers
8.3 Pravastatin Market Challenges
8.4 Pravastatin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pravastatin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pravastatin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pravastatin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pravastatin Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pravastatin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pravastatin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pravastatin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pravastatin Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pravastatin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pravastatin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pravastatin, Product Type & Application
 Table 12. Global Key Manufacturers of Pravastatin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pravastatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pravastatin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pravastatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pravastatin Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pravastatin Sales Market Share by Region (2020-2025)
 Table 19. Global Pravastatin Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pravastatin Sales Market Share by Region (2026-2031)
 Table 21. Global Pravastatin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pravastatin Revenue Market Share by Region (2020-2025)
 Table 23. Global Pravastatin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pravastatin Revenue Market Share by Region (2026-2031)
 Table 25. North America Pravastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pravastatin Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pravastatin Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pravastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pravastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pravastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pravastatin Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pravastatin Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pravastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pravastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pravastatin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pravastatin Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pravastatin Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pravastatin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pravastatin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pravastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pravastatin Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pravastatin Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pravastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pravastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pravastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pravastatin Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pravastatin Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pravastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pravastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pravastatin Sales (K Units) by Type (2020-2025)
 Table 51. Global Pravastatin Sales (K Units) by Type (2026-2031)
 Table 52. Global Pravastatin Sales Market Share by Type (2020-2025)
 Table 53. Global Pravastatin Sales Market Share by Type (2026-2031)
 Table 54. Global Pravastatin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pravastatin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pravastatin Revenue Market Share by Type (2020-2025)
 Table 57. Global Pravastatin Revenue Market Share by Type (2026-2031)
 Table 58. Global Pravastatin Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Pravastatin Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Pravastatin Sales (K Units) by Application (2020-2025)
 Table 61. Global Pravastatin Sales (K Units) by Application (2026-2031)
 Table 62. Global Pravastatin Sales Market Share by Application (2020-2025)
 Table 63. Global Pravastatin Sales Market Share by Application (2026-2031)
 Table 64. Global Pravastatin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pravastatin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pravastatin Revenue Market Share by Application (2020-2025)
 Table 67. Global Pravastatin Revenue Market Share by Application (2026-2031)
 Table 68. Global Pravastatin Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Pravastatin Price (USD/Unit) by Application (2026-2031)
 Table 70. Bristol-Myers Squibb Company Information
 Table 71. Bristol-Myers Squibb Description and Business Overview
 Table 72. Bristol-Myers Squibb Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bristol-Myers Squibb Pravastatin Product
 Table 74. Bristol-Myers Squibb Recent Developments/Updates
 Table 75. TEVA Company Information
 Table 76. TEVA Description and Business Overview
 Table 77. TEVA Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. TEVA Pravastatin Product
 Table 79. TEVA Recent Developments/Updates
 Table 80. SANDOZ Company Information
 Table 81. SANDOZ Description and Business Overview
 Table 82. SANDOZ Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. SANDOZ Pravastatin Product
 Table 84. SANDOZ Recent Developments/Updates
 Table 85. APOTEX Company Information
 Table 86. APOTEX Description and Business Overview
 Table 87. APOTEX Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. APOTEX Pravastatin Product
 Table 89. APOTEX Recent Developments/Updates
 Table 90. Dr. Reddy's Laboratories Company Information
 Table 91. Dr. Reddy's Laboratories Description and Business Overview
 Table 92. Dr. Reddy's Laboratories Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Dr. Reddy's Laboratories Pravastatin Product
 Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 95. Zydus Pharmaceuticals Company Information
 Table 96. Zydus Pharmaceuticals Description and Business Overview
 Table 97. Zydus Pharmaceuticals Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Zydus Pharmaceuticals Pravastatin Product
 Table 99. Zydus Pharmaceuticals Recent Developments/Updates
 Table 100. Cipla Inc. Company Information
 Table 101. Cipla Inc. Description and Business Overview
 Table 102. Cipla Inc. Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Cipla Inc. Pravastatin Product
 Table 104. Cipla Inc. Recent Developments/Updates
 Table 105. Lupin Pharmaceuticals Company Information
 Table 106. Lupin Pharmaceuticals Description and Business Overview
 Table 107. Lupin Pharmaceuticals Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Lupin Pharmaceuticals Pravastatin Product
 Table 109. Lupin Pharmaceuticals Recent Developments/Updates
 Table 110. Glenmark Company Information
 Table 111. Glenmark Description and Business Overview
 Table 112. Glenmark Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Glenmark Pravastatin Product
 Table 114. Glenmark Recent Developments/Updates
 Table 115. Mylan Company Information
 Table 116. Mylan Description and Business Overview
 Table 117. Mylan Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Mylan Pravastatin Product
 Table 119. Mylan Recent Developments/Updates
 Table 120. Aurobindo Pharma Company Information
 Table 121. Aurobindo Pharma Description and Business Overview
 Table 122. Aurobindo Pharma Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Aurobindo Pharma Pravastatin Product
 Table 124. Aurobindo Pharma Recent Developments/Updates
 Table 125. Accord Healthcare Company Information
 Table 126. Accord Healthcare Description and Business Overview
 Table 127. Accord Healthcare Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Accord Healthcare Pravastatin Product
 Table 129. Accord Healthcare Recent Developments/Updates
 Table 130. Upsher-Smith Laboratories Company Information
 Table 131. Upsher-Smith Laboratories Description and Business Overview
 Table 132. Upsher-Smith Laboratories Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Upsher-Smith Laboratories Pravastatin Product
 Table 134. Upsher-Smith Laboratories Recent Developments/Updates
 Table 135. Hisun Company Information
 Table 136. Hisun Description and Business Overview
 Table 137. Hisun Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Hisun Pravastatin Product
 Table 139. Hisun Recent Developments/Updates
 Table 140. Jiangxi Boyaseehot Pharmaceutical Company Information
 Table 141. Jiangxi Boyaseehot Pharmaceutical Description and Business Overview
 Table 142. Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Jiangxi Boyaseehot Pharmaceutical Pravastatin Product
 Table 144. Jiangxi Boyaseehot Pharmaceutical Recent Developments/Updates
 Table 145. Shanghai Shyndec Pharmaceutical Company Information
 Table 146. Shanghai Shyndec Pharmaceutical Description and Business Overview
 Table 147. Shanghai Shyndec Pharmaceutical Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Shanghai Shyndec Pharmaceutical Pravastatin Product
 Table 149. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
 Table 150. Daiichi Sankyo Company Information
 Table 151. Daiichi Sankyo Description and Business Overview
 Table 152. Daiichi Sankyo Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Daiichi Sankyo Pravastatin Product
 Table 154. Daiichi Sankyo Recent Developments/Updates
 Table 155. North China Pharmaceutical Group Company Information
 Table 156. North China Pharmaceutical Group Description and Business Overview
 Table 157. North China Pharmaceutical Group Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. North China Pharmaceutical Group Pravastatin Product
 Table 159. North China Pharmaceutical Group Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Pravastatin Distributors List
 Table 163. Pravastatin Customers List
 Table 164. Pravastatin Market Trends
 Table 165. Pravastatin Market Drivers
 Table 166. Pravastatin Market Challenges
 Table 167. Pravastatin Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pravastatin
 Figure 2. Global Pravastatin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pravastatin Market Share by Type: 2024 & 2031
 Figure 4. 10mg Tablet Product Picture
 Figure 5. 20mg Tablet Product Picture
 Figure 6. 40mg Tablet Product Picture
 Figure 7. 80mg Tablet Product Picture
 Figure 8. Global Pravastatin Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Pravastatin Market Share by Application: 2024 & 2031
 Figure 10. Adults
 Figure 11. Children
 Figure 12. Global Pravastatin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pravastatin Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pravastatin Sales (2020-2031) & (K Units)
 Figure 15. Global Pravastatin Average Price (USD/Unit) & (2020-2031)
 Figure 16. Pravastatin Report Years Considered
 Figure 17. Pravastatin Sales Share by Manufacturers in 2024
 Figure 18. Global Pravastatin Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pravastatin Players: Market Share by Revenue in Pravastatin in 2024
 Figure 20. Pravastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pravastatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pravastatin Sales Market Share by Country (2020-2031)
 Figure 23. North America Pravastatin Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pravastatin Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pravastatin Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pravastatin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pravastatin Revenue Market Share by Region (2020-2031)
 Figure 35. China Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Pravastatin Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Pravastatin Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Pravastatin Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Pravastatin Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Pravastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Pravastatin by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Pravastatin by Type (2020-2031)
 Figure 57. Global Pravastatin Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Pravastatin by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Pravastatin by Application (2020-2031)
 Figure 60. Global Pravastatin Price (USD/Unit) by Application (2020-2031)
 Figure 61. Pravastatin Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart